Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reviews in Endocrine and Metabolic Disorders
Literature
1.
2.
Koch CA. Endocrine hypertension: what is new? Rev Port Endocrinol Diabetes Metab. 2012;7(2):50–9.
3.
Fitch C, Keim KS. Academy of Nutrition and Dietetics. Position of the Academy of Nutrition and Dietetics: use of nutritive and nonnutritive sweeteners. J Acad Nutr Diet. 2012;112(5):739–58.CrossRefPubMed
4.
Yang Q. Gain weight by “going diet?” Artificial sweeteners and the neurobiology of sugar cravings: Neuroscience 2010. Yale J Biol Med. 2010;83(2):101–8.PubMedPubMedCentral
5.
Blum K, Chen AL, Giordano J, et al. The addictive brain: all roads lead to dopamine. J Psychoactive Drugs. 2012;44(2):134–43.CrossRefPubMed
6.
7.
Korpela K, Salonen A, Virta LJ, et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun. 2016;7:10410.CrossRefPubMedPubMedCentral
8.
Forslund K, Hildebrand F, Nielsen T, Dore J, MetaHIT consortium, Nielsen HB, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528(7581):262–6.CrossRefPubMedPubMedCentral
9.
Suez J, Korem T, Zeevi D, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;514(7521):181–6.PubMed
10.
Ebner J, Asci Arslan A, Fedorova M, Hoffmann R, Kucukcetin A, Pischetsrieder M. Peptide profiling of bovine kefir reveals 236 unique peptides released from caseins during its production by starter culture or kefir grains. J Proteomics. 2015;117:41–57.CrossRefPubMed
11.
12.
Lucan SC. Concerning limitations of food-environment research: a narrative review and commentary framed around obesity and diet-related diseases in youth. J Acad Nutr Diet. 2015;115(2):205–12.CrossRefPubMed
13.
Mennella JA, Bobowski NK, Reed DR. The development of sweet taste: from biology to hedonics. Rev Endocr Metab Disord 2016.
14.
Imamura F, O’Connor L, Ye Z, et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. Br J Sports Med. 2016;50(8):496–504.CrossRefPubMedPubMedCentral
15.
Drewnowski A, Brunzell JD, Sande K, Iverius PH, Greenwood MR. Sweet tooth reconsidered: taste responsiveness in human obesity. Physiol Behav. 1985;35(4):617–22.CrossRefPubMed
16.
Di Salle F, Cantone E, Savarese MF, Aragri A, Prinster A, Nicolai E, Sarnelli G, Iengo M, Buyckx M, Cuomo R. Effect of carbonation on brain processing of sweet stimuli in humans. Gastroenterology. 2013. 145(3):537–9.e3
17.
Spetter MS, Mars M, Viergever MA, de Graaf C, Smeets PA. Taste matters-effects of bypassing oral stimulation on hormone and appetite responses. Physiol Behav. 2014;137:9–17.CrossRefPubMed
18.
Kwok CS, Boekholdt SM, Lentjes MA, et al. Habitual chocolate consumption and risk of cardiovascular disease among healthy men and women. Heart. 2015;101(16):1279–87.CrossRefPubMed
19.
Hoch T, Pischetsrieder M, Hess A. Snack food intake in ad libitum fed rats is triggered by the combination of fat and carbohydrates. Front Psychol. 2014;5:250.CrossRefPubMedPubMedCentral
20.
de Araujo IE, Oliveira-Maia AJ, Sotnikova TD, et al. Food reward in the absence of taste receptor signaling. Neuron. 2008;57(6):930–41.CrossRefPubMed
21.
Rolls ET. Taste, olfactory, and food reward value processing in the brain. Prog Neurobiol. 2015;127–128:64–90.CrossRefPubMed
22.
23.
Jiang Y, Pan Y, Rhea PR, et al. A sucrose-enriched diet promotes tumorigenesis in mammary gland in part through the 12-lipoxygenase pathway. Cancer Res. 2016;76(1):24–9.CrossRefPubMed
24.
25.
Welge-Lüssen A, Dörig P, Wolfensberger M, Krone F, Hummel T. A study about the frequency of taste disorders. J Neurol. 2011;258(3):386–92.CrossRefPubMed
26.
Pischetsrieder M, Baeuerlein R. Proteome research in food science. Chem Soc Rev. 2009;38(9):2600–8.CrossRefPubMed
Metadata
Title
EDITORIAL: “The Koch’s” view on the sense of taste in endocrinology
Author
Christian A. Koch
Publication date
01-06-2016
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 2/2016
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-016-9383-y

Other articles of this Issue 2/2016

Reviews in Endocrine and Metabolic Disorders 2/2016 Go to the issue

EditorialNotes

Introduction to the sense of taste in endocrinology

ReviewPaper

Understanding the metabolic and health effects of low-calorie sweeteners: methodological considerations and implications for future research

ReviewPaper

Artificial sweeteners and metabolic dysregulation: Lessons learned from agriculture and the laboratory

ReviewPaper

Lipids and obesity: Also a matter of taste?

ReviewPaper

A Genome-Wide Association Study in isolated populations reveals new genes associated to common food likings

ReviewPaper

New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits